Livzon Pharmaceutical repurchases A-shares for cancellation

Livzon Pharmaceutical Group announced the repurchase of 85,300 A-shares on September 12, 2025, through the Shenzhen Stock Exchange. The repurchases were executed at prices ranging from RMB 39.91 to RMB 40.61 per share, totaling RMB 3,427,504. These shares are intended for cancellation.

This recent activity follows a series of A-share repurchases between December 2024 and September 2025. The company's total issued H-shares remained at 299,807,117 as of September 12, 2025, with zero treasury H-shares. The total issued A-shares stood at 604,293,313 on the same date, with zero treasury A-shares.

The repurchases are conducted in accordance with the Hong Kong Stock Exchange Listing Rules and relevant regulations of the Shenzhen Stock Exchange. All repurchased shares will be cancelled.